Bio Essence Stock Price, News & Analysis
Company Description
Bio Essence Corp. is an operating company whose common stock trades under the symbol BIOE and whose public-company materials describe a business focused on wellness and vitality through holistic products and practices. The company also describes growth strategies that include AI-enabled platform initiatives connected to health and wellness markets.
Bio Essence presents its business around two durable themes: a wellness-oriented operating identity and an emerging technology growth strategy. Its wellness description centers on lifestyle practices and holistic products, while its platform strategy refers to AI-enabled initiatives that may expand the company's activities beyond its existing core operations. The company's disclosures and public announcements also refer to capital-raising activity, material agreements, governance matters, and capital-structure topics.
The company is based in Irvine, California. Bio Essence announced approval for an upgrade to the OTCQB Venture Market, with its common stock trading under the BIOE ticker. The OTCQB status places the company within a market designed for entrepreneurial and development-stage issuers that maintain current reporting, annual verification, management certification, minimum bid standards, and governance requirements.
Stock Performance
Bio Essence (BIOE) stock last traded at $0.2740, down 8.68% from the previous close. Over the past 12 months, the stock has gained 19.1%. At a market capitalization of $11.4M, BIOE is classified as a micro-cap stock with approximately 38.0M shares outstanding.
BIOE Rankings
Latest News
Bio Essence has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include acquisition, AI, offering. View all BIOE news →
SEC Filings
Bio Essence has filed 5 recent SEC filings, including 2 Form 10-Q, 1 Form 8-K/A, 1 Form 8-K, 1 Form 10-K. The most recent filing was submitted on May 19, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BIOE SEC filings →
Financial Highlights
Bio Essence generated $1.9M in revenue over the trailing twelve months, retaining a 75.3% gross margin, operating income reached $900K (47.4% operating margin), and net income was $896K, reflecting a 47.2% net profit margin. Diluted earnings per share stood at $0.02. The company generated $1.6M in operating cash flow. With a current ratio of 0.17, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Bio Essence (BIOE) currently stands at 8.3 thousand shares, up 22.1% from the previous reporting period, representing 0.2% of the float. Over the past 12 months, short interest has increased by 22.1%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Bio Essence (BIOE) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
BIOE Company Profile & Sector Positioning
Bio Essence (BIOE) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.